• July 23, 2009
    RALEIGH, N.C.--How does site of injection affect the immunology of a bird when vaccinated in ovo? This question was addressed at the 2009 Poultry Science Association Meeting where Brett Hopkins, MS, DVM, Ph.D., DACPV, associate director for outcomes research with Pfizer Animal Health, presented data from a large scale commercial hatchery trial comparing the only two commercially available egg injection systems in the United Statesmore...
  • January 28, 2009
    DURHAM, N.C.--Infectious Bursal Disease (IBD) is an ongoing threat to the poultry industry. Fortunately, controlling it is a challenge that can be met efficiently and effectively with Bursaplex, a revolutionary Antigen Antibody Complex (AAC) vaccine developed by the scientists from the Poultry Health Division of Pfizer Animal Health (PPH). For over a decade, Bursaplex has consistently aided poultry producers worldwide to raise healthy flocksmore...
  • January 28, 2009
    DURHAM, N.C.--The same technology used in broiler and broilerbreeder operations worldwide has another important application: manufacturing of human flu vaccine. The Poultry Health Division of Pfizer Animal Health (PPH) supplies global manufacturers of human flu vaccine with two widely used technologies: the Embrex® Inovoject® System, and the Embrex Inovoject System - Egg Remover®. “Poultry eggs currently are used as amore...
  • January 28, 2009
    DURHAM, N.C.--The U.S. poultry industry has the potential to achieve new standards of health and efficiency with the advent of the first-ever coccidiosis vaccine delivered via in ovoadministration. The new Inovocox® vaccine from the Poultry Health Division of Pfizer Animal Health (PPH) will provide an innovative tool for the broiler industry to help control one of the global poultry industry’s most prevalent and costly diseases.more...
  • January 28, 2009
    DURHAM, N.C.--An ever-growing world population, coupled with increasing feed costs and production pressures, will make demands on the global poultry industry greater than ever in years ahead. Poised to meet those demands is the Poultry Health Division of Pfizer Animal Health (PPH), a hybrid of engineering and poultry animal health technology and innovation that was born via the acquisition of Embrex, Inc. by Pfizer Animal Health in 2007more...
  • March 18, 2008
    NEW YORK--(BUSINESS WIRE)--Pfizer Animal Health today announced it will acquire two market-leading livestock genomics companies: Catapult Genetics, Pty., Ltd., focused on developing and commercializing innovative livestock DNA tests and gene markers to assist global food producers, processors and retailers in improving profitability and quality in the global food chain; and Bovigen, LLC, which markets DNA technology, including Catapult’s productsmore...
  • January 24, 2008
    DURHAM, N.C.--The move follows the takeover of Embrex by Pfizer last year. The new poultry health division is designed to improve health productivity and costs in the poultry industry. Pfizer said that the Poultry Health Division will aim to improve their current products while developing new and integrated poultry health solutions. The division will aim to provide science, solutions, service and success, said Jimmore...
  • January 23, 2008
    DURHAM, N.C.--In ovo, or “in the egg” vaccination has been proven to be the most consistent and effective way to protect birds from disease. The Embrex® Inovoject® System delivers a precise, uniform injection to every egg, every time, offering the most versatile and reliable in ovo delivery platform available. “The Inovoject System has been in use for over 15 years and vaccinates over 35 million eggs per day worldwide,” says Jason Fryarmore...
  • January 23, 2008
    DURHAM, N.C.--Embrex® has been known worldwide for its industry leading customer service, and the new Poultry Health Division of Pfizer Animal Health is committed to providing the same exceptional service that customers have grown to trust. “The company is extremely service oriented,” says Dr. Don Ritter, Veterinarian at Mountaire Farms, a leading vertically-integrated poultry processor servicing customers from the United States andmore...
  • January 23, 2008
    DURHAM, N.C.--Human flu and the vaccines used to prevent it are a major focus in today’s medical world. The Poultry Health Division of Pfizer Animal Health supplies two device platforms for use in human flu vaccine manufacturing facilities –– The Embrex® Inovoject® Systems; Egg Remover® and the Embrex® Inovoject® System. Human flu vaccine is produced in eggs. The Egg Remover is used to provide an accurate, automatic and fast means of removingmore...